Companies / Maxx Orthopedics

Medical device company profile

Maxx Orthopedics

Knee and hip replacement implants, revision systems and outpatient arthroplasty workflow solutions.

Medical Device Manufacturer — Meril groupOrthopedics & MusculoskeletalJoint ReconstructionCommercial orthopedic implants and outpatient solutions

Headquarters🇺🇸Norristown, Pennsylvania, United States

Founded2007

Commercial statusCommercially availableKnee and hip systems commercially offered across multiple markets; specific product availability varies. U.S. PCK cone launch documented August 2026.

EmployeesNot confirmed

Estimated revenueNot confirmed

Official websitemaxxortho.com ↗

Company overview

Maxx Orthopedics is a joint replacement manufacturer headquartered in Norristown, Pennsylvania, United States. Its official company history dates its founding to 2007 and reports a presence in more than 60 markets. Maxx carries Meril branding; Meril states that it acquired Maxx Ortho in 2009. The portfolio serves hospitals and ambulatory surgery centers.

The main implant lines are Freedom knee systems and Libertas hip systems, spanning primary replacement, selected cementless options, partial knees and revision reconstruction. FDA records document component-specific 510(k) clearances, including porous tibial baseplates, Titan PCK components and metaphyseal cones.

Commercial expansion includes the UNIK personalized-instrument partnership announced in 2024, the February 2026 acquisition of TracPatch recovery-monitoring technology, and the August 2026 U.S. launch of PCK Metaphyseal Cones. QRS packages outpatient planning, instrumentation and recovery workflows. A manufacturer technical brief reports ten-year Freedom knee cohort results; those observations should not be generalized to newer implant variants or treated as comparative proof.

^{[35][36][38][40][42][49][50][59][60]}

Leadership

6 people

Ashesh ShahPresident and Chief Executive Officer ^[39]

Corey A. PerineChief Operating Officer ^[39]

Farzin KhaghaniChief Commercial Officer ^[39][41]

Danny MetcalfVice President of Strategic Initiatives ^[39]

Ross ChamberlainVice President of Business Development ^[39]

Simone MachanVice President of Operations ^[39]

Products & regulatory status How does MedTechIndex get this information?

Summary

The Freedom knee and Libertas hip families have multiple FDA 510(k) decisions, including component and material updates absent from the earlier snapshot. These are distinct regulatory decisions within product families, not separate product launches. Freedom Infinia and other unmapped configurations are retained separately rather than assumed to match an existing marketed model. ^{[54][56][52][2][16][35][37][1]}

No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. ^[32][30]

Regulatory snapshot How to read this snapshot

U.S. FDA

24
510(k) clearances: 0
De Novo grants: 0
PMA approvals: 0
Recall events

Latest recorded source review: 2026-10-20.

Scope: selected product families.

Commercial portfolio snapshot

Documented commercial product families.

Primary total knee replacement implants

Freedom Primary Knee System ↗

Cemented total knee family with femoral, tibial and polyethylene component choices. Includes primary configurations; individual variants have separate authorization histories. ^[58][46][50]

FDA-cleared